Concepedia

Publication | Closed Access

The serum <scp>IL</scp> ‐23 level predicts the response to pegylated interferon therapy in patients with chronic hepatitis B

DOI

10

Citations

16

References

2014

Year

Chengbo Yu, Xianli Gong, Qian Yang, Jiangshan Lian, Kaijin Xu, B Ruan, Lanjuan Li
Liver International

Abstract

A high pre-treatment serum IL-23 level predicts the therapeutic response in HBeAg-positive CHB patients during PegIFN therapy.

References

YearCitations

Page 1